Anthem (ANTM) Tops Q2 EPS by 14c

Anthem (NYSE: ANTM) reported Q2 EPS of $3.37, $0.14 better than the analyst estimate of $3.23. Revenue for the quarter came in at $22.2 billion versus the consensus estimate of $22.26 billion.

“I am pleased with our second quarter 2017 results, carrying forward our operating momentum. Our commitment to improving the quality and affordability of health care for our customers is resonating in the marketplace and benefiting our shareholders,\" said Joseph Swedish, president and chief executive officer.

“Our solid second quarter financial results reflect solid performance across our various business segments, which is reflected in our updated 2017 outlook,” said John Gallina, executive vice president and chief financial officer.

GUIDANCE:

• Anthem sees FY2017 EPS of $11.70, versus the consensus of $11.78.
• Medical membership is expected to be in the range of 40,200,000 - 40,400,000. Fully insured membership is now expected to be in the range of 15,200,000 - 15,300,000 and self-funded membership is expected to be in the range of 25,000,000 - 25,100,000.
• Operating revenue is now expected to be in the range of $88.5 - $89.5 billion.
• Benefit expense ratio is expected to be in the range of 87.0% plus or minus 30 basis points.
• SG&A ratio is expected to be in the range of 13.6% plus or minus 30 basis points.
• Operating cash flow is expected to be greater than $3.5 billion.

For earnings history and earnings-related data on Anthem (ANTM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• Cisco rating cut at HSBC as analyst sees a lack of catalysts